Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2283566 | chr16:89827610 | G/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2283567 | chr16:89849977 | A/C | 3.05E-5 | 173 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs2286393 | chr16:89809548 | C/A | 0.000223 | 172 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs2289959 | chr2:136423904 | C/T | 0.00021 | 178 | 25.53 | 25.67 | 14.5 | KM Plot |
PCPG | rs2290754 | chr1:243806268 | A/C | 0.000271 | 172 | 25 | 27.33 | 18.35 | KM Plot |
PCPG | rs2291361 | chr12:56717805 | G/A | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs2293584 | chr16:89888686 | C/G | 0.000192 | 173 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs2294445 | chr16:1725105 | T/C | 1.52E-11 | 175 | 25.47 | 18.2 | 4.52 | KM Plot |
PCPG | rs2294969 | chr22:28492151 | C/G | 5.55E-16 | 175 | 25.87 | 20.33 | 6.4 | KM Plot |
PCPG | rs2297703 | chr1:111731158 | C/T | 0.000263 | 178 | 19.87 | 28.3 | 25.47 | KM Plot |
PCPG | rs2301458 | chr16:1665110 | T/C | 1.56E-11 | 173 | 25 | 31.2 | 4.52 | KM Plot |
PCPG | rs2301901 | chr7:158707071 | A/G | 0 | 175 | 25.82 | 21.9 | 3.17 | KM Plot |
PCPG | rs2302162 | chr16:89845287 | A/G | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs2303226 | chr16:71604469 | A/G | 1.08E-5 | 174 | 25 | 30.93 | 14.5 | KM Plot |
PCPG | rs230397 | chr17:3275439 | A/G | 0.000438 | 170 | 18.2 | 25.43 | 27.2 | KM Plot |